Skip to main content

FY2012 NIH awards · Principal investigators

Pharmacology at Thomas Jefferson University

Philadelphia, PA

Funding
$1.5M
$1,493,729
Awards
6
FY2012 NIH awards in Pharmacology
Principal investigators
6
6 lead a grant here, 0 co-investigators
Department rank
#92
of 138 · Ranking
  • NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
  • These are the awards in the Pharmacology row of the Thomas Jefferson University page.

Leads a grant in this department

6 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

  1. Kraft, Walter K

    Leads 1 award · $471,121

    • 5R01DA029076-02Department: NIH department code
      A Comparison of Buprenorphine Versus Morphine in the Treatment of the Neonatal Ab
      $471,121
      award amount
  2. Tanaka, Takemi

    Leads 1 award · $321,625

    • 1R01CA160271-01A1Department: NIH department code
      Anti-Migration Therapy for Prevention and Treatment of Breast Tumor
      $321,625
      award amount
  3. Waldman, Scott A

    Leads 1 award · $321,625

    • 1R01CA170533-01Department: NIH department code
      GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1
      $321,625
      award amount
  4. Chervoneva, Inna

    Leads 1 award · $168,563

    • 5R21CA159816-02Department: NIH department code
      Semiparametric Methods for Efficiency-Adjusted Relative qRT-PCR Quantification
      $168,563
      award amount
  5. Fong, Louise Y.y.

    Leads 1 award · $168,563

    • 5R21CA152505-02Department: NIH department code
      Modulation of miR-31 by dietary zinc deficiency in rat esophageal carcinogenesis
      $168,563
      award amount
  6. Magee, Michael S.

    Leads 1 award · $42,232

    • 1F31CA171672-01Department: NIH department code
      GUCY2C targeted adoptive T cell therapy to treat metastatic colorectal cancer
      $42,232
      award amount